Articles from BIOTECH Patent News (June 1, 2007)

Title	Author	Type	Words
Bayer CropScience and Monsanto enter long-term business and license agreements for key enabling technologies agreements creating new choices and more options for farmers.			499
BioVeris completes merger with Roche.		Company overview	382
Cardica and Cook Medical enter new collaboration agreement to develop and commercialize closure device for heart defects.			694
Ciphergen licenses more than 25 patents from Health Discovery.			218
Ciphergen receives notice of intent from United States Patent and Trademark Office for re-Issuance of SELDI mass spectrometry patent.			175
Consumer groups file comments supporting United States Patent and Trademark Office's stem cell patent rejection '.			1277
General public supports breaking drug patents to ensure access to HIV/AIDS drugs in poorer countries.			407
Macrochem acquires option to license Pexiganan, a novel topical anti-infective for treatment of diabetic foot infection.			597
Nastech announces issuance of patents for parathyroid hormone nasal spray for osteoporosis.			510
Novavax licenses Wyeth's virus-like particle technology.			300
Oncolytics Biotech announces issuance of 6th Canadian patent.			138
Par Pharmaceutical licenses United States commercialization rights to antifungal Loramyc.			324
Pieris progresses development of its proprietary biotherapeutics platform.			534
Purac Biochem obtains United States patent.			84
Purdue obtains United States patent.		Brief article	105
Ruling in favor of Neuralstem leads to stay of Stemcells lawsuit.			368
United States Department of Energy obtains United States patent.			157
United States Patent and Trademark Office rejects Vitrolife patent claims.			227
University of California obtains United States patent.		Brief article	169
ZymoGenetics establishes global collaboration with Bayer for development and commercialization of recombinant human thrombin.			791